Surging Stocks Watch List - Immunomedics, (NASDAQ:IMMU), Yum! Brands, (NYSE:YUM), Synta Pharmaceuticals, (NASDAQ:SNTA), Hercules Offshore, (NASDAQ:HERO)

Surging Stocks Watch List - Immunomedics, (NASDAQ:IMMU), Yum! Brands, (NYSE:YUM), Synta Pharmaceuticals, (NASDAQ:SNTA), Hercules Offshore, (NASDAQ:HERO)

- in Business & Finance
0

On Friday, Shares of Immunomedics Inc. (NASDAQ:IMMU), gained 6.94% to $3.85.

Immunomedics, declared that it will host a conference call and live audio webcast on Thursday, May 7, 2015 at 10:00 a.m. Eastern Time to talk about financial results for the third quarter of fiscal year 2015, and review key clinical developments and future planned activities.

Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States.

At the end of Friday’s trade, Shares of Yum! Brands, Inc. (NYSE:YUM), jumped 6.91% to $91.90, hitting its highest level.

YUM! Brands, Board of Directors declared a dividend of $0.41 per share of common stock. The quarterly dividend will be distributed August 7, 2015, to shareholders of record at the close of business on July 17, 2015. Since initiating a dividend in 2004, Yum! has raised its dividend at a double-digit percentage rate each of the past ten years, placing Yum! in a select group of companies from the S&P 500 to do so.

YUM! Brands, Inc., together with its auxiliaries, operates quick service restaurants. It operates in five segments: YUM China, YUM India, the KFC Division, the Pizza Hut Division, and the Taco Bell Division.

Synta Pharmaceuticals Corp. (NASDAQ:SNTA), ended its last trade with 6.22% gain, and closed at $2.39.

Synta Pharmaceuticals, declared that it will report its first quarter 2015 financial results on Thursday, May 7, 2015, before market open.

Following the declaration, administration will host a conference call and webcast at 10:00 a.m. ET that morning to talk about the first quarter results and provide operational updates.

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. Its lead oncology drug candidate comprises ganetespib, an Hsp90 inhibitor, which is in Phase III clinical trial for the treatment of non-small cell lung cancer.

Finally, Hercules Offshore, Inc. (NASDAQ:HERO), closed at $0.8550, with 6.20% gain.

Hercules Offshore, declared that it has received a notice from Saudi Aramco extending the termination date of its drilling contract for the Hercules 261, to May 31, 2015. As formerly revealed, the company is in the process of seeking a basis for ongoing the Hercules 261 contract.

Hercules Offshore, Inc., together with its auxiliaries, provides shallow-water drilling and marine services to the oil and natural gas exploration and production industry worldwide. The company operates through Domestic Offshore, International Offshore, and International Liftboats segments.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.

Leave a Reply

Your email address will not be published. Required fields are marked *